Dewpoint Therapeutics is a biotechnology company applying the emerging science of biomolecular condensates to drug discovery. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional research site in Dresden, Germany, Dewpoint has built an AI-powered, end-to-end platform (ERSA, powered by ERSAi) spanning target discovery… - View it on GitHub